Source: Eur Respir J 2008; 32: 687-693
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marchand-Adam S., El Khatib A., Guillon F., Brauner M. W., Lamberto C., Lepage V., Naccache J-M., Valeyre D.. Short- and long-term response to corticosteroid therapy in chronic beryllium disease. Eur Respir J 2008; 32: 687-693

Member's Comments

No comment yet.

Related content which might interest you: Where current pharmacological therapies fall short in COPD: symptom control is not enough Source: Eur Respir Rev 2007; 16: 98-104 Year: 2007 Modern treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 60S-66S Year: 2001 Anabolic steroids in acute and chronic disease Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=163 Year: 2003 Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Source: Eur Respir J 2003; 21: 260-266 Year: 2003 Corticosteroid sensitivity in patients with chronic obstructive pulmonary disease is restored by theophylline Source: Annual Congress 2005 - Therapeutic options for COPD: present and future Year: 2005 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004 Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia Source: Eur Respir J 2013; 41: 402-409 Year: 2013 Why short-term antibiotic use in AECB may influence long-term outcomes Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Source: Eur Respir J 2001; 17: 337-342 Year: 2001 Chronic beryllium disease: azathioprine as a possible alternative to corticosteroid treatment Source: Eur Respir J 2013; 41: 234-236 Year: 2013 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients Source: Eur Respir J 2006; 27: 1190-1195 Year: 2006 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 A preliminary meta-analysis of long-term inhaled steroids for stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001